TRILEXA 25mcg+200mcg+62.5mcg BEXICAP contains Vilanterol 25 mcg + Fluticasone Furoate 200 mcg + Umeclidinium 62.5 mcg. It is a combination inhalation medicine used for the maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD) in appropriate patients.
Uses:
Maintenance treatment of asthma in adults.
Maintenance treatment of chronic obstructive pulmonary disease (COPD).
Prevention of bronchospasm and improvement of airflow.
Reduction of asthma and COPD exacerbations.
Dose:
Adults: Usually inhale the contents of 1 capsule once daily using the prescribed inhalation device, or as directed by a physician.
The capsule is for inhalation only and should not be swallowed.
Take the medicine exactly as prescribed by a healthcare professional.
Dose and duration depend on the patient's condition and response to treatment.